Harold Eugene Brakewood, Chief Business Officer at Immuneering Corp (IMRX), bought 3,900 shares at $2.57 ($10K) on 2024-03-22, disclosed to the SEC on 2024-03-25.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |